youtube.com/watch?v=ii1buo… Welcome to the Biocomputer!

Season’s Greetings Warmest compliments of the season from BiologIC! We wish all our friends, collaborators and partners a happy and healthy holiday with our sincerest appreciation for supporting our mission. Bring on 2022!

BiologIC biocomputer featured in New Electronics magazine. Our ambition is for the biocomputer to solve global challenges using biology in a powerful, sustainable and accessible way. See page 36! cdn.coverstand.com/66189/737702/5…

Are you a life science innovator? Responsible for creating new capabilities, scaling your business model and generating new insights using biology? Are you curious about how the latest industry 4.0 technologies will revolutionise your market? Contact us at: [email protected]

We are delighted that the government's UK Vaccine Network has supported us through a £475,000 grant to apply our biocomputer platform in the manufacture of RNA vaccines. Contact [email protected] Global Health Security, DHSC UK Department of Health and Social Care #RNA #celltherapy #genetherapy #vaccines #industry40

biologic-tech.com/component/cont… 1/ We’re delighted work with Oxford Biomedica, a leading gene and cell therapy group, to collaborate on a novel biocomputer system for viral vector development. BiologIC is the inventor of the biocomputer. Learn more at [email protected]

2/ BiologIC is the inventor of the biocomputer, a programmable system for producing biology and data on demand. Oxford Biomedica will use the platform to innovate new processes, integrate traditionally discrete workflows and gain valuable insights from real-time data.

Very excited to be part of this collaboration between BiologIC Technologies Ltd and Oxford Biomedica on developing a novel biocomputer system. biologic-tech.com/component/cont…

biologic-tech.com/news BiologIC, the biocomputer company, has been granted patents in the United States and Great Britain covering its foundational technology. For more information, please contact us at [email protected]

Our CEO, Richard Vellacott, was pleased to contribute to “Biopharma is Going Digital…Bit by Bit” in Genetic Engineering & Biotechnology News. biologic-tech.com/biopharma-is-g…

process.bio/biocomputer-wh… We’re delighted to share our new whitepaper “Introduction to the Biocomputer”, which describes the world first biocomputer platform for application developers.

BiologIC Technologies, the biocomputer company, has received an investment from CPI Enterprises, a recognised leader in bioprocessing innovation and collaboration partner in mRNA and monoclonal antibody manufacturing. #therapy #cellandgenetherapy #industry40

Forbes describes the biocomputer as “the most simple yet versatile biomanufacturing system in the world”. forbes.com/sites/johncumb…

Our CEO, Richard Vellacott, co-authored a DNA synthesis paper published in Nature Reviews Chemistry: nature.com/articles/s4157…

biologic-tech.com/nucleic-acid-m… BiologIC, the biocomputer company, has won a prestigious grant aimed at advancing the development and manufacturing of nucleic acid therapies. #RNA #DNA #therapy

We collaborate with BiologIC Technologies Ltd to shorten #mRNA vaccine development timelines making them more easily available for use in case of a novel outbreak or a pandemic threat shorturl.at/v6gKW

Can we halve the time it takes to get to clinic with a new vaccine? We’re excited to find out in our new collaboration with eminent scientists CEPI

Deep space - the ultimate challenge for distributed biomanufacturing! We’re excited to adapt our precision bioprocessing platform modules for semi-autonomous microgravity operation in partnership with UK Space Agency